(S (NP (NP (NNP Predicting)) (IN whether) (NP (NP (DT a) (JJ chemical) (NN structure) (NNS shares)) (NP (DT a) (VBN desired) (JJ biological) (NN effect)))) (VP (MD can) (VP (VB have) (NP (NP (DT a) (JJ significant) (NN impact)) (PP (IN for) (NP (NP (NML (PP (IN in) (HYPH -) (NP (FW silico)))) (NN compound) (NN screening)) (PP (IN in) (NP (JJ early) (NN drug) (NN discovery)))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD developed) (NP (DT a) (JJ deep) (NN learning) (NN model)) (SBAR (WHADVP (WRB where)) (S (NP (NN compound) (NNS structures)) (VP (VBP are) (VP (VP (VBN represented) (PP (IN as) (NP (NNS graphs)))) (CC and) (ADVP (RB then)) (VP (VBN linked) (PP (IN to) (NP (PRP$ their) (JJ biological) (NN footprint))))))))) (. .))
(S (S (VP (TO To) (VP (VB make) (NP (DT this) (JJ complex) (NN problem)) (ADVP (RB computationally)) (S (ADJP (JJ tractable)))))) (, ,) (NP (JJ compound) (NNS differences)) (VP (VBD were) (VP (VBN mapped) (PP (IN to) (NP (NP (JJ biological) (NN effect) (NNS alterations)) (VP (VBG using) (NP (NP (JJ Siamese) (NN Graph)) (NP (NNP Convolutional) (JJ Neural) (NNS Networks)))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN model)) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VP (VB learn) (NP (JJ new) (NNS representations)) (PP (IN from) (NP (JJ chemical) (NNS structures)))) (CC and) (VP (VB identify) (NP (NP (ADJP (RB structurally) (JJ dissimilar)) (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (JJ similar) (JJ biological) (NNS processes)) (PP (IN with) (NP (JJ high) (NN precision))))))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (PP (IN by) (S (VP (VBG utilizing) (NP (JJ deep) (NNS ensembles)) (S (VP (TO to) (VP (VB estimate) (NP (NN uncertainty)))))))) (, ,) (NP (PRP we)) (VP (VBD were) (ADJP (JJ able) (S (VP (TO to) (VP (VB provide) (NP (ADJP (JJ reliable) (CC and) (JJ accurate)) (NNS predictions)) (PP (IN for) (NP (NP (JJ chemical) (NNS structures)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (RB very) (JJ different) (PP (IN from) (NP (NP (DT the) (NNS ones)) (VP (VBN used) (PP (IN during) (NP (NN training))))))))))))))))) (. .))
(S (ADVP (RB Finally)) (, ,) (NP (PRP we)) (VP (VBP present) (S (NP (NP (DT a) (JJ novel) (NN inference) (NN approach)) (, ,) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (VBN trained) (NNS models)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB estimate) (NP (NP (DT the) (NN signaling) (NNS pathways)) (VP (VBN affected) (PP (IN by) (NP (NP (DT a) (NN compound) (NN perturbation)) (PP (IN in) (NP (DT a) (JJ specific) (NN cell) (NN line)))))))))))))) (, ,)) (VP (VBG using) (NP (RB only) (PRP$ its) (JJ chemical) (NN structure)) (PP (IN as) (NP (NN input)))))) (. .))
(S (PP (IN As) (NP (DT a) (NN use) (NN case))) (, ,) (NP (DT this) (NN approach)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB infer) (NP (NP (NN signaling) (NNS pathways)) (VP (VBN affected) (PP (IN by) (NP (ADJP (NNP FDA) (HYPH -) (VBN approved)) (JJ anticancer) (NNS drugs)))))))))) (. .))
